Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of…

By M. Rybak, B. Lomaestro, J. Rotschafer, R. Moellering, W. Craig, M. Billeter, J. Dalovisio, D. Levine. American Journal of Health-System Pharmacy, 2019

1,788 citations recorded by the source corpus.

Vancomycin is a glycopeptide antibiotic that has been in clinical use for nearly 50 years as a penicillin alternative to treat penicillinase-producing strains of Staphylococcus aureus . It is one of the most widely used antibiotics in the United States for the treatment of serious gram-positive

Subfields: Clinical Biochemistry, Infectious Diseases, Pharmacology

View Paper: https://www.semanticscholar.org/paper/f97f86b0eb5acbf0d7b5f8d4197a9e67f28c94ab

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Biochemistry

1. D. Levine
2. Robert S. Daum
3. S. Cosgrove
4. B. Lomaestro
5. J. Rotschafer
6. M. Billeter
7. J. Dalovisio
8. R. Moellering

In Infectious Diseases

1. D. Levine
2. Robert S. Daum
3. S. Cosgrove
4. B. Lomaestro
5. J. Rotschafer
6. M. Billeter
7. J. Dalovisio
8. R. Moellering

In Pharmacology

1. B. Lomaestro
2. J. Rotschafer
3. D. Levine
4. J. Dalovisio
5. M. Billeter
6. R. Moellering

Citations in the corpus

• Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Socie (2020, methodology): “loading doses for severe infections in patients who were seriously ill.(1)”
• Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. (2013, background): “R ec en t gu id el in es [7 , 8] fo r th e tr ea tm en t of m et hi ci lli nre si st an t St ap hy lo co cc us au re us (M R S A ) in fe ct io ns ha ve be en pu bl is he d.”
• Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. (2011, background): “What are the recommendations for vancomycin dosing and monitoring? These recommendations are based on a consensus statement of the American Society of Health-System Pharmacists, the IDSA, and The Society of Infectious Diseases Pharmacists on guidelines for vancomycin dosing [3, 4].”
• Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. (2009, background): “comycin.[1] A computerized literature search of PubMed for”